Maze Therapeutics Inc.

NASDAQ: MAZE · Real-Time Price · USD
13.49
0.14 (1.05%)
At close: Aug 15, 2025, 3:59 PM
13.50
0.07%
After-hours: Aug 15, 2025, 05:38 PM EDT

Maze Therapeutics Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023
Revenue
2.5M 167.5M 167.5M 167.5M 165M n/a n/a n/a
Cost of Revenue
2.83M 2.18M 2.44M 2.71M 2.93M 2.93M 1.98M 1M
Gross Profit
462K 166.11M 165.84M 165.57M 162.07M -2.93M -1.98M -1M
Operating Income
-125.83M 50.2M 57.59M 64.26M 63.26M -76.29M -48.28M -25.23M
Interest Income
5.98M 6.99M 4.65M 3.44M 2.08M 1.07M 785K 481K
Pretax Income
-121.35M 53.11M 53.4M 56.68M 56.96M -83.82M -51.32M -24.75M
Net Income
-120.8M 51.94M 52.23M 55.23M 55.24M -83.82M -51.32M -24.75M
Selling & General & Admin
30.57M 28.1M 26.42M 25.91M 24.81M 18.91M 12.78M 5.77M
Research & Development
97.76M 89.2M 83.5M 77.33M 76.93M 57.38M 35.5M 19.46M
Other Expenses
-1.33M -684K n/a n/a n/a n/a n/a n/a
Operating Expenses
127M 116.62M 109.91M 103.24M 101.74M 76.29M 48.28M 25.23M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
128.33M 117.3M 109.91M 103.24M 101.74M 76.29M 48.28M 25.23M
Income Tax Expense
-554K 1.17M 1.17M 1.45M 1.73M n/a n/a n/a
Shares Outstanding (Basic)
43.85M 43.8M 43.8M 43.78M n/a 43.8M 43.78M 43.78M
Shares Outstanding (Diluted)
43.85M 43.8M 43.8M 43.78M n/a 43.8M 43.78M 43.78M
EPS (Basic)
-1.68 -0.92 -0.91 -1.4 -1.91 -1.91 -1.17 -0.57
EPS (Diluted)
-1.68 -0.92 -0.91 -1.4 -1.91 -1.91 -1.17 -0.57
EBITDA
-124.34M 52.55M 60.88M 67.83M 67.05M -73.36M -46.3M -24.22M
EBIT
-120.42M 52.81M 57.59M 64.26M 63.26M -76.29M -48.28M -25.23M
Depreciation & Amortization
2.18M 3.03M 3.3M 3.57M 3.78M 2.93M 1.98M 1M